Contact
Please use this form to send email to PR contact of this press release:
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel
TO:
Please use this form to send email to PR contact of this press release:
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel
TO: